Weill Cornell Medicine, 1300 York Avenue, New York, NY, 10065, USA.
Weill Cornell Medicine, Department of Radiology, 525 East 68th street, New York, NY 10065, USA.
Clin Imaging. 2021 Feb;70:114-117. doi: 10.1016/j.clinimag.2020.09.014. Epub 2020 Oct 7.
Image-guided core needle biopsy (CNB) is the standard of care procedure for tissue diagnosis of suspicious breast lesions. While complications are exceedingly rare, the most common complications include bleeding and hematoma formation. With an increasing number of patients on anticoagulation therapy (AT), it is important to determine whether continuation of these medications during CNB increases bleeding risk. While previous studies have demonstrated the safety in continuation of AT during CNB, American College of Radiology (ACR) guidelines recommend practitioners decide whether cessation is necessary on a case-by-case basis as this may put patients at risk for thromboembolic events. The purpose of this review is to analyze the literature on anticoagulation and bleeding risk during CNB to guide clinical practice.
影像引导下核心针活检（CNB）是疑似乳腺病变组织诊断的标准护理程序。虽然并发症极为罕见，但最常见的并发症包括出血和血肿形成。随着接受抗凝治疗（AT）的患者数量不断增加，确定在 CNB 期间继续使用这些药物是否会增加出血风险非常重要。虽然之前的研究已经证明了在 CNB 期间继续使用 AT 的安全性，但美国放射学院（ACR）指南建议从业者根据具体情况决定是否需要停药，因为这可能使患者面临血栓栓塞事件的风险。本综述的目的是分析关于 CNB 期间抗凝和出血风险的文献，以指导临床实践。
